Market revenue in 2023 | USD 280.3 million |
Market revenue in 2030 | USD 945.2 million |
Growth rate | 19% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 48.95% in 2023. Horizon Databook has segmented the Italy dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing R&D investments and continuous research by scientists have boosted the demand for innovative NGS solutions in Italy. For instance, in March 2020, using Thermo Fisher Scientific’s NGS research assay, a team of Italian researchers analyzed the SARS-CoV-2 genome from specimens collected locally and suggested that the rapidly spreading virus's genome is stable.
In the recent past, the Italian biotechnology industry has shown notable growth due to major academic and industrial research. According to data published by the International Trade Administration (ITA), in August 2019, the biotechnology sector is one of the rapidly growing sectors in Italy, which generated a turnover of over USD 13.6 billion, with an increase of 16.0% between 2014 and 2018.
The same source stated that R&D investments in biotechnology sector amounted to around USD 2.0 billion with about 4,317 employees in biotech research. Thus, increasing research investments and initiatives in the country are anticipated to boost demand for advanced NGS solutions for research applications.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Italy dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account